A woman has taken to the internet to share the biggest difference she experienced when switching between GLP-1 drugs Wegovy ...

Eli Lilly said on Thursday its experimental weight-loss pill met most criteria for the U.S. Food and Drug Administration's ...

Judging from the numbers I'm seeing, the black market for weight-loss jabs isn't small-scale. This is a massive operation.

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Wegovy can help people with excess weight and obesity lose ...

The Wegovy and Ozempic maker’s offer comes after Pfizer last month agreed to a lower deal to acquire the Nasdaq-listed ...

A severely anorexic young woman was prescribed blockbuster weight loss jab Wegovy by one of the UK's biggest online ...

Explore the fierce competition between Novo Nordisk and Pfizer as they vie for Metsera amidst a booming obesity drug market.

Metsera has become the obesity drug market's hottest ticket. The New York-based biotech is at the centre of a bidding war ...

Denmark's Novo Nordisk said on Thursday it has made an unsolicited bid for U.S. drug maker Metsera , after Pfizer in ...

Metsera, Inc. is at the center of a bidding war between Novo Nordisk and Pfizer, driving its stock up 20%. Learn more about ...

Lilly’s quarterly results Thursday, combined with Novo Nordisk’s unsolicited offer for a startup, confirm the $72 billion ...

LONDON (Reuters) -Novo Nordisk's late bid to hijack Pfizer's takeover of U. obesity biotech Metsera marks an aggressive shift ...